Accueil >
Publications >
Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072

Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072

1 juil. 2016Gynecologic Oncology

DOI : 10.1016/j.ygyno.2016.03.024

Auteurs

C. Benson, I. Ray-Coquard, S. Sleijfer, S. Litière, J.-Y. Blay, A. Le Cesne, Z. Papai, I. Judson, P. Schöffski, S. Chawla, T. Gil, S. Piperno-Neumann, S. Marréaud, M.R. Dewji, W.T.A. van der Graaf